These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2696853)

  • 1. [Insulin--its past, present and future].
    Grujić M; Hrisafović Z; Kulenović I
    Med Arh; 1989; 43(1):45-50. PubMed ID: 2696853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin's 85th anniversary--An enduring medical miracle.
    Heller S; Kozlovski P; Kurtzhals P
    Diabetes Res Clin Pract; 2007 Nov; 78(2):149-58. PubMed ID: 17482306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
    Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
    Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled drug delivery in the treatment of diabetes mellitus.
    Irsigler K; Kritz H; Lovett RG
    Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of porcine and human regular insulins using an artificial pancreas].
    Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J; Monnier L
    Nouv Presse Med; 1982 Nov; 11(45):3331-3. PubMed ID: 6760120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement treatment with insulin in diabetes mellitus: problems and promise.
    Dupre J; Champion MC; Rodger NW
    Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of artificial beta-cells or programmed insulin infusions in the therapy of insulin-dependent diabetes mellitus].
    Bruns W; Fischer U
    Z Gesamte Inn Med; 1981 Sep; 36(17):625-7. PubMed ID: 7048769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump therapy (continuous subcutaneous insulin infusion).
    White RD
    Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR; Rakel RE
    Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
    Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically controlled closed-loop insulin delivery.
    Ravaine V; Ancla C; Catargi B
    J Control Release; 2008 Nov; 132(1):2-11. PubMed ID: 18782593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human insulin.
    Raptis S; Dimitriadis G
    Clin Physiol Biochem; 1985; 3(1):29-42. PubMed ID: 3888492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reliable and new aspects of insulin therapy].
    Walter H
    Z Gesamte Inn Med; 1993 Mar; 48(3):135-9. PubMed ID: 8475637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of high-purity insulins in the treatment of patients with diabetes mellitus].
    Spesivtseva VG; Pokryshkin VI; Belokrinitskiĭ ; Koroleva TV; Mamaeva GG
    Ter Arkh; 1987; 59(11):22-6. PubMed ID: 3327181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.